Asthma
COPD
Pulmonary
COPD: Page 12
Phase 1 trial begins for COPD treatment
Monoclonal antibody aimed at patients with moderate to severe COPD.
March 29, 2024
Three pharmaceutical companies cap prices on asthma, COPD inhalers
Move could make it easier to encourage patient compliance.
March 25, 2024
AstraZeneca begins phase III clinical trial on Breztri
THARROS trial will examine potential improvements in cardiopulmonary outcomes.
March 18, 2024
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
ALA releases new COPD Trends brief
Latest report underscores critical need for oxygen reform.
March 11, 2024
First patient dosed in phase 2 COPD treatment trial
RLS-0071 is being tested for acute exacerbations of COPD in hospitalized patients.
March 11, 2024
Dupixent accepted for FDA priority review
The drug will be reviewed for treatment of COPD with type 2 inflammation.
March 4, 2024
Sponsored
CDC respiratory virus guidance
Ascend Media
Review recommendations and updates to help prevent illness.
April 10, 2025
First patient tested in COPD ventilation system clinical trial
AeriSeal system shows promise in limiting collateral ventilation.
March 4, 2024
Gut microbiome plays pivotal role in COPD development
Research could pave the way for new treatments.
February 28, 2024
FDA clears first over-the-counter fingertip pulse oximeter
Device provides patients with COPD a way to assess blood oxygen levels.
February 28, 2024
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
Reproductive factors in women linked to heightened COPD risk
Menstruation, miscarriage, infertility and other factors cited in study.
February 19, 2024
Patients with COPD could see improved health from lifestyle changes
Researchers find behavior change interventions lead to health benefits.
February 19, 2024
Pulmonary rehab for patients with COPD is difficult to access
Study finds millions are more than an hour away from needed care.
February 13, 2024
Previous Page
Page 12 of 17
Next Page
Most Popular
GINA releases 2025 asthma guidelines update
Brinsupri becomes first FDA-approved therapy for NCFB
Alternative inflammatory pathways drive residual asthma exacerbations in children treated with mepolizumab
Machine learning model enhances asthma drug prediction accuracy
Zinc’s emerging role in pediatric asthma, allergic rhinitis
Researchers create 3D-printed living lung tissue